NTRK
genes and cancer: when arresting the fusion underlies the treatment
Epigenomics
.
2021 Apr;13(8):561-564.
doi: 10.2217/epi-2021-0003.
Epub 2021 Apr 7.
Authors
Khalil El Gharib
1
,
Hampig R Kourie
1
Affiliation
1
Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University, Beirut 17-5208, Lebanon.
PMID:
33825542
DOI:
10.2217/epi-2021-0003
No abstract available
Keywords:
NTRK; entrectinib; fusion inhibitors; larotrectinib.
Publication types
Editorial
MeSH terms
Gene Fusion
Humans
Neoplasms / genetics*
Protein-Tyrosine Kinases / genetics*
Substances
Protein-Tyrosine Kinases